Legal & General Group’s Viking Therapeutics VKTX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $3.27M | Buy |
123,348
+6,172
| +5% | +$164K | ﹤0.01% | 1752 |
|
2025
Q1 | $2.83M | Buy |
117,176
+9,806
| +9% | +$237K | ﹤0.01% | 1794 |
|
2024
Q4 | $4.32M | Sell |
107,370
-745
| -0.7% | -$30K | ﹤0.01% | 1650 |
|
2024
Q3 | $6.84M | Buy |
108,115
+6,606
| +7% | +$418K | ﹤0.01% | 1413 |
|
2024
Q2 | $5.38M | Buy |
101,509
+5,222
| +5% | +$277K | ﹤0.01% | 1489 |
|
2024
Q1 | $7.9M | Buy |
96,287
+781
| +0.8% | +$64K | ﹤0.01% | 1274 |
|
2023
Q4 | $1.78M | Buy |
95,506
+906
| +1% | +$16.9K | ﹤0.01% | 2003 |
|
2023
Q3 | $1.05M | Sell |
94,600
-202
| -0.2% | -$2.24K | ﹤0.01% | 2169 |
|
2023
Q2 | $1.54M | Buy |
94,802
+64,493
| +213% | +$1.05M | ﹤0.01% | 2042 |
|
2023
Q1 | $505K | Buy |
+30,309
| New | +$505K | ﹤0.01% | 2314 |
|
2022
Q2 | – | Sell |
-24,729
| Closed | -$74K | – | 3664 |
|
2022
Q1 | $74K | Hold |
24,729
| – | – | ﹤0.01% | 2931 |
|
2021
Q4 | $114K | Hold |
24,729
| – | – | ﹤0.01% | 2883 |
|
2021
Q3 | $156K | Buy |
24,729
+13,023
| +111% | +$82.2K | ﹤0.01% | 2753 |
|
2021
Q2 | $70K | Buy |
11,706
+528
| +5% | +$3.16K | ﹤0.01% | 2848 |
|
2021
Q1 | $70K | Buy |
11,178
+3,899
| +54% | +$24.4K | ﹤0.01% | 2722 |
|
2020
Q4 | $41K | Hold |
7,279
| – | – | ﹤0.01% | 2857 |
|
2020
Q3 | $42K | Sell |
7,279
-2,677
| -27% | -$15.4K | ﹤0.01% | 2752 |
|
2020
Q2 | $72K | Buy |
9,956
+594
| +6% | +$4.3K | ﹤0.01% | 2620 |
|
2020
Q1 | $44K | Sell |
9,362
-3,326
| -26% | -$15.6K | ﹤0.01% | 2636 |
|
2019
Q4 | $102K | Buy |
12,688
+981
| +8% | +$7.89K | ﹤0.01% | 2588 |
|
2019
Q3 | $81K | Hold |
11,707
| – | – | ﹤0.01% | 2591 |
|
2019
Q2 | $98K | Hold |
11,707
| – | – | ﹤0.01% | 2539 |
|
2019
Q1 | $116K | Buy |
11,707
+1,003
| +9% | +$9.94K | ﹤0.01% | 2449 |
|
2018
Q4 | $82K | Buy |
10,704
+2,945
| +38% | +$22.6K | ﹤0.01% | 2509 |
|
2018
Q3 | $135K | Buy |
7,759
+1,264
| +19% | +$22K | ﹤0.01% | 2426 |
|
2018
Q2 | $62K | Buy |
+6,495
| New | +$62K | ﹤0.01% | 2659 |
|